This is because amyloidosis is associated with many defects in platelet function and coagulation, including abnormal platelet aggregation, increased vascular fragility, factor IX and factor X deficiency, decreased alpha-2-plasmin inhibitor levels, and increased plasminogen levels [17, 18]. Here, F9 is linked to amyloidosis.